Effect of DPP4 Inhibitors on Cisplatin-induced Acute Kidney Injury

Trial Profile

Effect of DPP4 Inhibitors on Cisplatin-induced Acute Kidney Injury

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 25 Apr 2016

At a glance

  • Drugs Gemigliptin (Primary) ; Cisplatin
  • Indications Acute kidney injury
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Apr 2016 Planned End Date changed from 1 Oct 2016 to 1 Jun 2018.
    • 18 Apr 2016 Planned primary completion date changed from 1 Oct 2015 to 1 Feb 2018.
    • 29 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top